CORPORATE FACT SHEET December 2013 Acceleron is a biopharmaceutical company committed to discover, develop, manufacture and commercialize novel protein therapeutics for cancer and orphan diseases Acceleron’s scientific

First Page		Document Content
Date: 2013-12-03 10:00:27 Hematology Anemias Hematopathology Celgene Myelodysplastic syndrome Beta-thalassemia Transforming growth factor beta Thalassemia Diamond–Blackfan anemia Medicine Health Biology		CORPORATE FACT SHEET December 2013 Acceleron is a biopharmaceutical company committed to discover, develop, manufacture and commercialize novel protein therapeutics for cancer and orphan diseases Acceleron’s scientific Add to Reading List Source URL: www.acceleronpharma.com Download Document from Source Website File Size: 535,04 KB Share Document on Facebook

	DOC Document DocID: 1rs8N - View Document
	DEPARTMENT OF PATHOLOGY University at Buffalo Pathology Residency Program Description and Overview Program: Four Year Combined Anatomic and Clinical Pathology The 4-year combined Anatomic/Clinical Pathology training prog DocID: 1rnhv - View Document
	Nutrition News for Africa NovemberAnemia in low-income and middle-income countries. Balarajan Y, DocID: 1rip8 - View Document
	88012 Rubratope-57 Cyano Capsul:53 am DocID: 1qI38 - View Document
	S7 LOKO Erythrapheresis Final [Mode de compatibilité] DocID: 1q1Ba - View Document